SPOTLIGHT -
Ms Kuntz is the assistant managing editor of Psychiatric Times.
How Does Your Salary Stack Up Against Your Colleagues?
Let's talk about money...
Defective Cilia in the Brain Linked to Schizophrenia
Mutations in PCM1, a gene crucial to neuronal cilia function, have been connected with schizophrenia, according to a recent study.
One of the First US In Vitro Diagnostic Tests for Assessment of Alzheimer Disease
The Lumipulse® G β-Amyloid Ratio in vitro diagnostic test was filed for 510(k) premarket clearance.
Dlgap2: The Gene Associated With Memory Loss
A new study associates a gene that facilitates neuron communication in the nervous system with memory loss.
Is Child Maltreatment Associated with Substance Use? New Evidence Emerges
Female emergency department patients with adverse childhood experiences were more likely to have substance use issues.
LGBTQ+ Individuals who Abuse Substances Are More Likely to Have Psychiatric Disorders
Sexual minorities with alcohol and tobacco addictions are at a higher risk for comorbid psychiatric disorders, bisexual women in particular.
Pregnancy and Postpartum Suicide Risk: The New Numbers
Suicide attempts among pregnant or postpartum mothers have nearly tripled over the past decade.
A Shift in the Air: Changes in Young Adults’ Vaping and Substance Use During COVID-19
How has the COVID-19 pandemic affected the way young adults use substances like vaping, alcohol, and marijuana?
Experts Share Clinical Tips and Insights at 2020 Annual Psychiatric Times® World CME Conference™
Key leaders experienced in real-world clinical practice share on a range of topics.
Antidepressant Drug Helps Prevent Deterioration in Patients With COVID-19
Fluvoxamine was not intended as a COVID-19 medication, but a recent study suggests it may help prevent serious complications for patients with COVID-19.
FDA Applies Brakes to Schizophrenia Drug Approval Due to Manufacturing Concerns
Manufacturing issues stall progress with ALKS 3831, Alkermes’s promising new drug for the treatment of schizophrenia and bipolar I disorder.
Helping Young People Diagnosed With Psychosis Develop Identities
New research underlies the need for addressing identity in young patients during early stages of psychosis.
A New Way to “Watch” Your Nightmares
A new prescription smartwatch app may improve sleep quality for those with nightmare disorders.
Deep Transcranial Magnetic Stimulation: A New Solution to Obsessive-Compulsive Disorder
Recently published data suggests a promising new treatment for patients with obsessive-compulsive disorder.
Poster Presentation Sheds Light on Alzheimer Disease Preventative Treatments
Good news in the fight against Alzheimer disease, with major progress in new, innovative treatments.
Statistics of Suicide
Here are some statistics around suicide to help put things in perspective.
The Neurobiological Mechanism for Hallucinations and Delusions
An explanation for the clinical presentation of delusions and hallucinations may have just been found.
Proposed Treatment for ADHD Suffers Setback
A potential treatment for attention-deficit/hyperactivity disorder goes back to the drawing board.
The Decline of Child Antipsychotic Medications
Antipsychotic medications for young children are not being prescribed appropriately, according to a recent study.
Is Social Media Making Your Patients Unhappy?
Have you chatted recently with your patients about their social media use? This study shows how and why it is important.
Are Women More Frequently Diagnosed With Anxiety and Depression?
A study in Spain uncovers the hard truth about gender inequality in mental health care.
The Intersection of Excessive Alcohol Use and Psychiatric Disorders
A diagnosis of depression, anxiety disorders, or bulimia may also indicate a heightened risk of excessive drinking.
Evidence-Based Treatments for PTSD
What treatments are there to assist in the rehabilitation of veterans?
The Link Between Depressive Symptoms and Stroke Risk in Black and White Individuals
Does race affect the risk of stroke in patients with depression? A new study finds some answers and some new questions.
Six-Month Long-Acting Treatment for Schizophrenia in the Works
A new, unique long-acting injectable for treating schizophrenia may be on the way.
Motor Neuron Medication May Assist in Treatment of PTSD
A recent study found riluzole may effectively combat hyperarousal symptoms in combat veterans with PTSD.
Treatment on the Horizon for Alcohol Use Disorder
Adial Pharmaceuticals announced the reactivated US Investigational application for their Alcohol Use Disorder therapeutic agent, AD04.
New Data Supports Use of Digital Treatment for ADHD
Akili announces new data on treatment EndeavorRx that reports real-world improvement for children with ADHD.
Remove the Stigma Around Binge Eating Disorder
Carlos M. Grilo, PhD, explained symptoms, causes, and treatment for binge-eating disorder in his talk at The Annual Psychiatric Times® World CME Conference™.
Algorithms for Improved Practice
Can algorithms improve how you practice? Dr Osser explained more in his speech at the Annual Psychiatric Times® World CME Conference™.